Received Dec 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | Z27PB | — |
wrong administration of an adult dose of HAVRIX to a 6-year-old patient; wrong administration of an adult dose of HAVRIX to a 6-year-old patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 6-year-old female patient who received HAV (Havrix adult) (batch number Z27PB, expiry date 27-AUG-2026) for prophylaxis. On 05-DEC-2025, the patient received the 2nd dose of Havrix adult. On 05-DEC-2025, an unknown time after receiving Havrix adult, the patient experienced adult product administered to child (Verbatim: wrong administration of an adult dose of HAVRIX to a 6-year-old patient) and overdose (Verbatim: wrong administration of an adult dose of HAVRIX to a 6-year-old patient). The outcome of the adult product administered to child and overdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-DEC-2025 The medical assistant called to report the wrong administration of an adult dose of Havrix to child (patient).